A detailed history of Everence Capital Management Inc transactions in Bio Techne Corp stock. As of the latest transaction made, Everence Capital Management Inc holds 7,100 shares of TECH stock, worth $504,455. This represents 0.04% of its overall portfolio holdings.

Number of Shares
7,100
Previous 7,100 -0.0%
Holding current value
$504,455
Previous $449,000 26.5%
% of portfolio
0.04%
Previous 0.03%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Jan 30, 2024

SELL
$52.83 - $78.22 $175,923 - $260,472
-3,330 Reduced 31.93%
7,100 $548,000
Q3 2023

Oct 16, 2023

BUY
$67.52 - $89.42 $704,233 - $932,650
10,430 New
10,430 $710,000
Q4 2022

Jan 31, 2023

BUY
$80.67 - $352.29 $324,293 - $1.42 Million
4,020 Added 300.0%
5,360 $444,000
Q4 2021

Jan 28, 2022

BUY
$456.15 - $525.06 $611,241 - $703,580
1,340 New
1,340 $693,000

Others Institutions Holding TECH

About BIO-TECHNE Corp


  • Ticker TECH
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 39,222,600
  • Market Cap $2.79B
  • Description
  • Bio-Techne Corporation, together with its subsidiaries, develops, manufactures, and sells life science reagents, instruments, and services for the research and clinical diagnostic markets worldwide. The company operates through two segments, Protein Sciences, and Diagnostics and Genomics. The Protein Sciences segment develops and manufactures bi...
More about TECH
Track This Portfolio

Track Everence Capital Management Inc Portfolio

Follow Everence Capital Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Everence Capital Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Everence Capital Management Inc with notifications on news.